134 related articles for article (PubMed ID: 38251800)
1. Predicting disability and mortality in CV2/CRMP5-IgG associated paraneoplastic neurologic disorders.
Uysal SP; Li Y; Thompson NR; Milinovich A; Abbatemarco JR; Cohen JA; Conway DS; Ontaneda D; Morren JA; Kunchok A
Ann Clin Transl Neurol; 2024 Mar; 11(3):710-718. PubMed ID: 38251800
[TBL] [Abstract][Full Text] [Related]
2. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies.
Honnorat J; Cartalat-Carel S; Ricard D; Camdessanche JP; Carpentier AF; Rogemond V; Chapuis F; Aguera M; Decullier E; Duchemin AM; Graus F; Antoine JC
J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):412-6. PubMed ID: 18931014
[TBL] [Abstract][Full Text] [Related]
3. CV2/CRMP5-antibody-related Paraneoplastic Optic Neuropathy Associated with Small-cell Lung Cancer.
Nakajima M; Uchibori A; Ogawa Y; Miyazaki T; Ichikawa Y; Kaneko K; Takahashi T; Nakashima I; Shiraishi H; Motomura M; Chiba A
Intern Med; 2018 Jun; 57(11):1645-1649. PubMed ID: 29321433
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases.
Dubey D; Lennon VA; Gadoth A; Pittock SJ; Flanagan EP; Schmeling JE; McKeon A; Klein CJ
Neurology; 2018 Jan; 90(2):e103-e110. PubMed ID: 29222126
[TBL] [Abstract][Full Text] [Related]
5. [Neurologic paraneoplastic syndrome with anti-CV2/CRMP5 antibodies revealing a small cell lung cancer. Effectiveness of the lung cancer treatment].
Rosencher L; Maisonobe T; Lavole A; Milleron B; Ferroir JP
Rev Neurol (Paris); 2012 Apr; 168(4):371-4. PubMed ID: 22387203
[TBL] [Abstract][Full Text] [Related]
6. An overview on CV2/CRMP5 antibody-associated paraneoplastic neurological syndromes.
Wang S; Hou H; Tang Y; Zhang S; Wang G; Guo Z; Zhu L; Wu J
Neural Regen Res; 2023 Nov; 18(11):2357-2364. PubMed ID: 37282453
[TBL] [Abstract][Full Text] [Related]
7. CRMP5 antibodies in patients with small-cell lung cancer or thymoma.
Monstad SE; Drivsholm L; Skeie GO; Aarseth JH; Vedeler CA
Cancer Immunol Immunother; 2008 Feb; 57(2):227-32. PubMed ID: 17657489
[TBL] [Abstract][Full Text] [Related]
8. [A case of paraneoplastic myelopathy associated with anti-CV2/CRMP5 antibodies with small-cell lung cancer].
Sato C; Kano T; Yabe I; Sasaki H
Rinsho Shinkeigaku; 2020 Aug; 60(8):560-564. PubMed ID: 32641628
[TBL] [Abstract][Full Text] [Related]
9. Collapsin Response-Mediator Protein 5-Associated Retinitis, Vitritis, and Optic Disc Edema.
Cohen DA; Bhatti MT; Pulido JS; Lennon VA; Dubey D; Flanagan EP; Pittock SJ; Klein CJ; Chen JJ
Ophthalmology; 2020 Feb; 127(2):221-229. PubMed ID: 31676123
[TBL] [Abstract][Full Text] [Related]
10. Amphiphysin-IgG autoimmune neuropathy: A recognizable clinicopathologic syndrome.
Dubey D; Jitprapaikulsan J; Bi H; Do Campo RV; McKeon A; Pittock SJ; Engelstad JK; Mills JR; Klein CJ
Neurology; 2019 Nov; 93(20):e1873-e1880. PubMed ID: 31624089
[TBL] [Abstract][Full Text] [Related]
11. Mechanism, and treatment of anti-CV2/CRMP5 autoimmune pain.
Martin L; Stratton HJ; Gomez K; Do LD; Loya-Lopez S; Tang C; Calderon-Rivera A; Ran D; Nunna V; Bellampalli SS; François-Moutal L; Dumaire N; Salih L; Luo S; Porreca F; Ibrahim M; Rogemond V; Honnorat J; Khanna R; Moutal A
bioRxiv; 2024 May; ():. PubMed ID: 38766071
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous Regression of Small Cell Lung Carcinoma and Associated Hemichorea.
Shibata K; Nishimura Y; Sakura H
Intern Med; 2021 Dec; 60(23):3817-3821. PubMed ID: 34148955
[TBL] [Abstract][Full Text] [Related]
13. Microtubule-associated protein 1B: Novel paraneoplastic biomarker.
Gadoth A; Kryzer TJ; Fryer J; McKeon A; Lennon VA; Pittock SJ
Ann Neurol; 2017 Feb; 81(2):266-277. PubMed ID: 28074593
[TBL] [Abstract][Full Text] [Related]
14. Collapsin response mediator protein 5-associated optic neuropathy: clinical characteristics, radiologic clues, and outcomes.
Yan R; Mao Y; Zeng H; Liu Q; Jiang H; Peng J; Yang Q; Cui S; Liu L; Guo Y; Wang J
Front Neurol; 2023; 14():1163615. PubMed ID: 37448746
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer.
Bataller L; Wade DF; Graus F; Stacey HD; Rosenfeld MR; Dalmau J
Neurology; 2004 Mar; 62(5):778-82. PubMed ID: 15007130
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic Choreoathetosis in a Patient with Small Cell Lung Carcinoma and Anti-CRMP5/CV2: A Case Report.
Aydin D; Somnier F; Lassen LH
Case Rep Neurol; 2016; 8(1):16-9. PubMed ID: 26889151
[TBL] [Abstract][Full Text] [Related]
17. Anti-CV2/CRMP5 antibody-positive paraneoplastic neurological syndromes with chronic intestinal pseudo-obstruction in a small-cell lung cancer patient: a case report and literature review.
Yan J; Chen Z; Liang Y; Yang H; Cao L; Zhou Y; Zhao Y; Zhang Y
J Int Med Res; 2020 Dec; 48(12):300060520974466. PubMed ID: 33305627
[TBL] [Abstract][Full Text] [Related]
18. CV2/CRMP5-antibody-related Paraneoplastic Neurologic Syndrome Associated with Gastrointestinal Stromal Tumor.
Fukushima H; Shibuya T; Awatsu T; Kurosawa T; Haga K; Murakami T; Serizawa N; Mori A; Hojo M; Yao T; Hattori N; Nagahara A
Intern Med; 2022 May; 61(10):1497-1501. PubMed ID: 34670904
[TBL] [Abstract][Full Text] [Related]
19. Devic's syndrome-like phenotype associated with thymoma and anti-CV2/CRMP5 antibodies.
Ducray F; Roos-Weil R; Garcia PY; Slesari J; Heinzlef O; Chatelain D; Toussaint P; Roullet E; Honnorat J
J Neurol Neurosurg Psychiatry; 2007 Mar; 78(3):325-7. PubMed ID: 17308295
[No Abstract] [Full Text] [Related]
20. Paraneoplastic Myeloneuropathies: Clinical, Oncologic, and Serologic Accompaniments.
Shah S; Vazquez Do Campo R; Kumar N; McKeon A; Flanagan EP; Klein C; Pittock SJ; Dubey D
Neurology; 2021 Jan; 96(4):e632-e639. PubMed ID: 33208548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
